Quench Bio is a biotechnology company leveraging new insights into gasdermin biology and innate immunity to develop medicines for severe inflammatory diseases. Quench’s lead compounds target and inhibit the pore-forming protein Gasdermin D, a central player in both pyroptosis and NETosis pathways that mediates the release of inflammatory cytokines, alarmins, DNA and NETs.
| Website | http://www.quenchbio.com |
| Employees | 15 (0 on RocketReach) |
| Founded | 2018 |
| Technologies | |
| Industry | Biotechnology, Drug Discovery |
| Keywords | Immune Response, Biotechnology, Innovative Therapies, Innate Immunity, Inflammatory Diseases, Drug Discovery, Immunology, Biologics, Therapeutics, Medicine Development, Pharmaceutical, Biopharma, Clinical Trials, New Medicines, Disease Treatment |
| Competitors | AstraZeneca, Amgen, BioMarin Pharmaceutical Inc., Zymeworks Inc., Sangamo Therapeutics, Inc., Seres Therapeutics, Evozyne, Zymergen, Inc., Arzeda, Lilly India +41 more (view full list) |
Looking for a particular Quench Bio employee's phone or email?
Quench Bio Questions
Quench Bio is based in Cambridge, Massachusetts.
Related Companies
G2Crowd Trusted
300K+
Plugin Users
